• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

弥漫性类似肝硬化的肝细胞癌:一种临床上和影像学上无法检测到的变异型,模仿肝硬化。

Diffuse cirrhosis-like hepatocellular carcinoma: a clinically and radiographically undetected variant mimicking cirrhosis.

机构信息

Department of Pathology, Rush University Medical Center, Chicago, IL 60612, USA.

出版信息

Am J Surg Pathol. 2010 Jul;34(7):935-41. doi: 10.1097/PAS.0b013e3181ddf52f.

DOI:10.1097/PAS.0b013e3181ddf52f
PMID:20463569
Abstract

A rare variant of hepatocellular carcinoma (HCC) is encountered that produces small cirrhosis-like nodules diffusely throughout the liver (CL-HCC), instead of a larger evident mass. This pattern remains undetected as carcinoma clinically and radiographically and is unexpectedly discovered after liver transplantation in the explanted native liver. We studied 10 such cases (9 males and 1 female, age 35 to 80 y) from 4 medical centers. The pretransplant clinical, laboratory, and radiographical studies were reviewed to determine the cause and stage of liver disease, alpha-fetoprotein (AFP) levels, and detectability of a mass on imaging. All 10 cases had underlying cirrhosis of varying etiology [3 hepatitis C virus (HCV), 3 alcoholic hepatitis, 1 hepatitis B virus, 1 autoimmune, and 2 mixed HCV/alcoholic hepatitis and hemochromatosis/HCV] and underwent orthotopic liver transplantation with no preoperative clinical suspicion of HCC. Ultrasound and/or dynamic imaging showed cirrhosis and no definite HCC. AFP levels were only mildly elevated in only 3 of 10 cases (144, 150, and 252 ng/mL). Grossly, there were innumerable (from about 20 to >1000) small CL-HCC nodules (0.2 to 0.6 cm) scattered among cirrhotic nodules. Histologically, these were well or moderately differentiated HCC, often with pseudoglandular pattern, perinodular sclerotic rims, cholestasis, frequent Mallory bodies, and small vessel invasion. In addition to the usual HCC immunophenotype, CL-HCC showed frequent ubiquitin and cytoplasmic and membranous CD10 positivity, relatively low Ki-67 proliferative index and absence of AFP immunohistochemically. CL-HCC warrants recognition as a unique HCC variant that evades pretransplant detection despite massive tumor burden, mimics cirrhotic nodules, and shows some uncommon pathologic and immunophenotypical characteristics.

摘要

弥漫性小结节性肝细胞癌的一种罕见变异型,其特点为肝脏内弥漫性分布小结节,类似于小结节性肝硬化,而非较大的明显肿块。这种表现临床上和影像学上均无法识别为癌,且在肝移植时于供肝中意外发现。我们研究了来自 4 个医学中心的 10 例此类病例(9 名男性,1 名女性;年龄 35 至 80 岁)。回顾分析了患者的移植前临床、实验室和影像学检查资料,以明确肝病的病因和分期、甲胎蛋白(AFP)水平,以及影像学上能否发现肿块。所有 10 例患者均存在不同病因所致的基础肝硬化[3 例丙型肝炎病毒(HCV)、3 例酒精性肝炎、1 例乙型肝炎病毒、1 例自身免疫性疾病和 2 例 HCV/酒精性肝炎合并血色病/HCV],并接受了原位肝移植,术前无 HCC 的临床怀疑。超声和/或动态成像显示肝硬化,无明确 HCC。10 例患者中仅 3 例 AFP 轻度升高(分别为 144、150 和 252ng/ml)。大体上,肝脏内可见无数(约 20 至>1000 个)直径 0.2 至 0.6cm 的小结节性肝硬化伴弥漫性肝细胞癌(CL-HCC)结节。组织学上,这些为分化良好或中等分化 HCC,常呈假腺管样结构,伴结节周围硬化性边缘、胆汁淤积、Mallory 小体多见、小血管侵犯。CL-HCC 除了具有 HCC 的常见免疫表型外,还常表现为泛素和细胞质及膜 CD10 阳性,Ki-67 增殖指数相对较低,免疫组化法不表达 AFP。CL-HCC 是一种独特的 HCC 变异型,尽管肿瘤负荷巨大,但仍可逃避移植前检测,其表现类似小结节性肝硬化,且具有一些不常见的病理和免疫表型特征。

相似文献

1
Diffuse cirrhosis-like hepatocellular carcinoma: a clinically and radiographically undetected variant mimicking cirrhosis.弥漫性类似肝硬化的肝细胞癌:一种临床上和影像学上无法检测到的变异型,模仿肝硬化。
Am J Surg Pathol. 2010 Jul;34(7):935-41. doi: 10.1097/PAS.0b013e3181ddf52f.
2
Alpha fetoprotein, ultrasound, computerized tomography and magnetic resonance imaging for detection of hepatocellular carcinoma in patients with advanced cirrhosis.甲胎蛋白、超声、计算机断层扫描和磁共振成像用于检测晚期肝硬化患者的肝细胞癌。
Aliment Pharmacol Ther. 2007 Nov 1;26(9):1187-94. doi: 10.1111/j.1365-2036.2007.03498.x.
3
Alpha-fetoprotein as a tumor marker in hepatocellular carcinoma: investigations in south Indian subjects with hepatotropic virus and aflatoxin etiologies.甲胎蛋白作为肝细胞癌的肿瘤标志物:对南印度感染嗜肝病毒和黄曲霉毒素致病的受试者的研究
Int J Infect Dis. 2008 Nov;12(6):e71-6. doi: 10.1016/j.ijid.2008.04.010. Epub 2008 Jul 26.
4
Hepatocellular carcinoma and its early detection by AFP testing in Mongolia.蒙古的肝细胞癌及其通过甲胎蛋白检测进行早期诊断
Asian Pac J Cancer Prev. 2006 Jul-Sep;7(3):460-2.
5
Development of Risk Prediction Model for Hepatocellular Carcinoma Progression of Indeterminate Nodules in Hepatitis B Virus-Related Cirrhotic Liver.乙肝相关肝硬化肝脏中不确定结节肝细胞癌进展风险预测模型的开发
Am J Gastroenterol. 2017 Mar;112(3):460-470. doi: 10.1038/ajg.2016.480. Epub 2016 Oct 25.
6
Alpha-Fetoprotein Measurement Benefits Hepatocellular Carcinoma Surveillance in Patients with Cirrhosis.甲胎蛋白检测对肝硬化患者肝细胞癌监测有益。
Am J Gastroenterol. 2015 Jun;110(6):836-44; quiz 845. doi: 10.1038/ajg.2015.100. Epub 2015 Apr 14.
7
Evaluating patients with cirrhosis for hepatocellular carcinoma: value of clinical symptomatology, imaging and alpha-fetoprotein.评估肝硬化患者的肝细胞癌:临床症状、影像学检查及甲胎蛋白的价值
Oncology. 2007;72 Suppl 1:117-23. doi: 10.1159/000111717. Epub 2007 Dec 13.
8
Hepatocellular carcinoma in Belgium: clinical and virological characteristics of 154 consecutive cirrhotic and non-cirrhotic patients.比利时肝细胞癌:154例连续性肝硬化和非肝硬化患者的临床及病毒学特征
Eur J Gastroenterol Hepatol. 2000 Jan;12(1):61-6.
9
[Hepatocellular carcinoma in Germany. Epidemiology, etiology, clinical aspects and prognosis in 100 consecutive patients of a university clinic].[德国的肝细胞癌。一所大学诊所100例连续患者的流行病学、病因、临床情况及预后]
Z Gastroenterol. 1997 Dec;35(12):1059-67.
10
Diagnostic sensitivity of hepatocellular carcinoma imaging and its application to non-cirrhotic patients.肝细胞癌影像学诊断的敏感性及其在非肝硬化患者中的应用。
J Gastroenterol Hepatol. 2011 Apr;26(4):745-50. doi: 10.1111/j.1440-1746.2010.06501.x.

引用本文的文献

1
Homozygous missense variants in YKT6 result in loss of function and are associated with developmental delay, with or without severe infantile liver disease and risk for hepatocellular carcinoma.YKT6 中的纯合错义变异导致功能丧失,并与发育迟缓相关,无论是否伴有严重婴儿期肝病和肝细胞癌风险。
Genet Med. 2024 Jul;26(7):101125. doi: 10.1016/j.gim.2024.101125. Epub 2024 Mar 21.
2
Advances in Histological and Molecular Classification of Hepatocellular Carcinoma.肝细胞癌组织学和分子分类的进展
Biomedicines. 2023 Sep 20;11(9):2582. doi: 10.3390/biomedicines11092582.
3
Educational Case: Evaluating a patient with cirrhosis.
教育案例:评估一名肝硬化患者。
Acad Pathol. 2022 Jul 1;9(1):100031. doi: 10.1016/j.acpath.2022.100031. eCollection 2022.
4
Imaging Spectrum of Intrahepatic Mass-Forming Cholangiocarcinoma and Its Mimickers: How to Differentiate Them Using MRI.肝内肿块型胆管细胞癌及其模拟病变的影像学表现:MRI 如何对其进行鉴别。
Curr Oncol. 2022 Jan 30;29(2):698-723. doi: 10.3390/curroncol29020061.
5
Efficacy of expressions of Arg-1, Hep Par-1, and CK19 in the diagnosis of the primary hepatocellular carcinoma subtypes and exclusion of the metastases.Arg-1、Hep Par-1 和 CK19 表达在原发性肝细胞癌亚型诊断中的作用及对转移瘤的排除。
Histol Histopathol. 2021 Sep;36(9):981-993. doi: 10.14670/HH-18-361. Epub 2021 Jul 13.
6
Pathologic and molecular features of hepatocellular carcinoma: An update.肝细胞癌的病理和分子特征:最新进展
World J Hepatol. 2021 Apr 27;13(4):393-410. doi: 10.4254/wjh.v13.i4.393.
7
Cirrhotomimetic hepatocellular carcinoma: experience of a single institution and review of the literature.
Hepat Oncol. 2020 Aug 21;8(1):HEP28. doi: 10.2217/hep-2020-0015.
8
Pearls and pitfalls in magnetic resonance imaging of hepatocellular carcinoma.肝细胞癌的磁共振成像的要点与陷阱。
World J Gastroenterol. 2020 May 7;26(17):2012-2029. doi: 10.3748/wjg.v26.i17.2012.
9
Infiltrative non-mass-like hepatocellular carcinoma initially presenting with isolated malignant portal vein thrombosis: A case report and review of the literature.以孤立性恶性门静脉血栓形成初发的浸润性无肿块型肝细胞癌:1例报告并文献复习
J Ultrason. 2020;20(80):e55-e60. doi: 10.15557/JoU.2020.0009. Epub 2020 Mar 31.
10
Clinical Features and Clonal Origin of Diffuse Hepatocellular Carcinoma.弥漫性肝细胞癌的临床特征与克隆起源
Chin Med J (Engl). 2018 May 5;131(9):1128-1131. doi: 10.4103/0366-6999.230725.